Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil combined with nalbuphine for epidural labor analgesia
ChiCTR2000029698Phase 4Not yet recruiting
- Sponsor
- Qingdao Women and Children’s Hospital
- Start
- Jan 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sufentanil, nalbuphine and ropivacaine in labor pain (3 arms), sponsored by Qingdao Women and Children’s Hospital. Primary endpoints: Onset time of analgesia, Time to first patient-controlled analgesia request and 2 more. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
sufentanilnalbuphineropivacaine
03
Conditions
labor pain
Beyond the preview
Go deeper on ChiCTR2000029698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029698.